The Nordic-American Life Science Conference, organized by Business Sweden, DNB, NASDAQ and partners took place for the first time on November 30th – December 1st in New York. The conference gathered Nordic life science and healthcare technology companies, as well as U.S. investors, business developers and external innovation scouts during two inspiring and intense days of 1-on-1 meetings, high level panel discussions and networking sessions.
The Nordic-American Life Science Conference aims to be the number one Nordic life science meeting in the U.S.
We look forward to seeing you at The Nordic-American Life Science Conference in December 2017!
To learn more, please visit our conference website: www.nalsconference.com
Key figures from the 2016 Conference:
- 180+ attendees from eight different countries
- 10+ Nordic attendees
- 30+ Swedish and 20 other Nordic Therapeutics, Diagnostics, Medtech and Digital Health companies
- 40+ Investors and BD executives
- 36 panel and workshop speakers
- 30 company pitches
Some of the Investors, Industry & Speakers included:
Sanofi-Genzyme BioVentures, Pfizer Venture Investments, OrbiMed, Boehringer Ingelheim Venture Fund, MPM Capital, Aisling Capital, AbbVie Ventures, Broadview Ventures, New Enterprise Associates, Philips Ventures, MVM Life Science Partners, Aporia Advisors, H.I.G. Capital, Fountain Healthcare Partners, Citadel LLC/Surveyor Capital, MSF Capital Advisors, MedPro Investors, GC Finance, Federated Investors, Lerner Associates, Magid Family Office, HealthCap, Industrifonden, Serendipity Partners, Citigroup, Deutsche Bank, Merck, Alexion Pharmaceuticals, Mylan, Regeneron, Pfizer, Roche Innovation Center New York, Bristol-Myers Squibb, LabCorp, Teleflex, IBM Watson Health, The New York Stem Cell Foundation.
